COMPANY PROFILE

Huichuang Medical

Explore full profile

Providing innovative, professional solutions and services for neuroscience R&D

Haidian, ChinaFounded 2016Health Tech & Medtech

Valuation $50–100M Last recorded · 2024

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Huichuang Medical

HCmedx specializes in leveraging functional near infrared spectroscopy (fNIRS) technology to enhance adaptive decision-making and emotion regulation across various applications. The company focuses on providing advanced monitoring and evaluation tools that utilize fNIRS to assess brain activity and cortical activation. Their solutions are particularly impactful in environments such as air traffic control and rehabilitation, where precise and adaptive decision-making is critical. HCmedx serves a diverse range of clients, including healthcare providers, rehabilitation centers, and research institutions. Operating in the medical technology and neuroscience markets, the company employs a business model centered around the development and sale of specialized fNIRS-based products and services. Revenue is generated through product sales, service contracts, and research collaborations.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: Haidian, China
Open positions: None listed
Dealroom signal: 23.0/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Rehabilitation, Neurology, Health Diagnostics, Hard Tech, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2b
Investment activity: 1 company, latest Jul 2026
Capital deployed: $0
Preferred round: EARLY VC
Links: Website

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	May 2024	$14M	$55M	Xingfu Capital · ShengJing360	↗
SERIES B✓Equity / VC	Oct 2023	$14M	$55M	Leaguer Tsing-Yuan Venture Capital · Zhongke Haichuang · Addor Capital · Wuxi Venture Capital Group	↗

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Huichuang Medical website traffic

Latest recorded traffic for Huichuang Medical is 1.1K monthly website visits, down 57.7% over the last three months.

Latest monthly visits1.1K 3-month web change-57.7%

Monthly website visitsAug 2020–Nov 2024

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
NENeuroelectricsDeveloping a unique platform to treat brain dysfunction with cloud-based, personalized neuromodulation	Barcelona, Spain	Operational	64	$35M	$70M
ANAleva NeurotherapeuticsPioneered directional deep brain stimulation DBS in Neuromodulation treatment of Parkinson's disease and essential tremor	Lausanne, Switzerland	Operational
MIMindMazeDigital neuro-therapeutics for brain health and recovery	Lausanne, Switzerland	Acquired
AIAi-BrainScienceA medical device manufacturing and sales business	Suita-Shi, Japan	Operational
PNPhantom NeuroCreates a system that will enable lifelike control of robotic orthopedic technologies	Austin, United States	Operational
MAmachineMDRadically improving the early diagnosis of brain disorders	Bern, Switzerland	Operational
I(Inrobics (NaoTherapist)AI-powered social robots for rehabilitation therapies	Leganés, Spain	Operational
ININBRAIN NeuroelectronicsHigh-resolution graphene interfaces for precision neurology.	Barcelona, Spain	Operational